Background Benzodiazepines are commonly prescribed medications, especially among elderly, despite known risks and guidelines focused on short term usage. There is an increased trend of benzodiazepine consumption in Croatia. Consumption of anxiolytics in 2015 and 2016 in Croatia can almost entirely be ascribed to benzodiazepines, with diazepam being the most commonly prescribed drug, followed by alprazolam. Objective The aim of this study was to examine benzodiazepine utilization habits among the Croatian population. Setting This study was conducted on the national level, based on digital prescribing data. Method Data regarding the prescription of anxiolytics in Croatia was sourced and analyzed from the Croatian Health Insurance Fund database for the years 2015 and 2016. Drugs included in the study were classified according to The Anatomical and Therapeutic Classification of Medicines System, and consist of several chemical therapeutic subgroups (N05BA, N05BC, N05CD, N05CF). Main outcome measures The prescribing frequency of the most often prescribed benzodiazepines in Croatia. Results The total number of benzodiazepine prescriptions was 5,085,695 in 2015, and 5,294,075 in 2016; this represents a 208,380 increase in prescriptions, or 4.1% more than the previous year. The number of patients who utilized benzodiazepines showed an increase from 860,664 (8.67%) in 2015 to 876,046 (8.76%) in 2016. In relation to gender, benzodiazepine consumption was higher among female patients in all age groups, with the number of utilized benzodiazepine prescriptions per patient being highest in the oldest age group (80 +), comprising 7 prescriptions per patient in a 12 months period. Conclusion Increased utilization and long-term treatment with benzodiazepines remains a serious challenge for the health care system in Croatia. National prescription guidelines, improved control of benzodiazepine usage and prescriptions, along with restricted release drug lists, should all be considered as potential measures to rationalize benzodiazepine prescription, control unnecessary expenditure in the country and improve the well-being of the patients.
Benzodiazepine Croatia Drug utilization Inappropriate medication Prescription
This is a preview of subscription content, log in to check access.
Authors would like to thank Croatian Health Insurance Fund for providing the data analyzed in this article.
The authors received no funding for this work.
Conflicts of interest
All authors declare that they have no conflict of interest regarding the work presented in the manuscript.
Spanemberg L, Nogueira EL, da Silva CT, Dargél AA, Menezes FS, Cataldo Neto A. High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. Gen Hosp Psychiatr. 2011;33:45–50.CrossRefGoogle Scholar
Llorente MD, David D, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatr Neurol. 2000;13:150–60.CrossRefGoogle Scholar
Noto AR, Carlini EA, Mastroianni PC, Alves VC, Galduroz JC, Kuroiwa W, et al. Analysis of prescription and dispensation of psychotropic medications in two cities in the State of São Paulo, Brazil. Braz J Psychiatr. 2002;24:68–73.CrossRefGoogle Scholar
Rodrigues MA, Facchini LA, Lima MS. Modificações nos padrões de consumo de psicofármacos em localidade do Sul do Brasil. Rev Saude Publica. 2006;40:107–14.PubMedCrossRefGoogle Scholar
Živković K, Zelić A, Štimac D, Ožić S, Živković N. A study on the quality of outpatient prescription of psychopharmaceuticals in the City of Zagreb 2006–2009. Coll Antropol. 2014;38:717–24.PubMedGoogle Scholar
García MAF, de Labry Lima AO, Ferrer Lopez I, Bermúdez-Tamayo C. Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs. J Pharm Policy Pract. 2018;11:1.PubMedPubMedCentralCrossRefGoogle Scholar
Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatr Dis Treat. 2009;5:341–54.PubMedPubMedCentralCrossRefGoogle Scholar
Bourgeois J, Elseviers MM, Azermai M, van Bortel L, Petrovic M, Vander Stichele RR. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol. 2012;68:833–44.PubMedCrossRefGoogle Scholar
Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Longterm use of benzodiazepines: definitions, prevalence and usage patterns—a systematic review of register-based studies. Eur Psychiatry. 2015;30:1037–47.PubMedCrossRefGoogle Scholar
Siriwardena AN, Qureshi MZ, Dyas JV, Middleton H, Orner R. Magic bullets for insomnia? Patients’ use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Br J Gen Pract. 2008;58:417–22.PubMedPubMedCentralCrossRefGoogle Scholar
Peritogiannis V, Manthopoulou T, Mavreas V. Long-term benzodiazepine treatment in patients with psychotic disorders attending a mental health service in rural Greece. J Neurosci Rural Pract. 2016;7:S26–S30.PubMedPubMedCentralGoogle Scholar
Johnell K, Fastbom J. The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatr. 2009;24:731–8.CrossRefGoogle Scholar
Hoffmann F, Hies M, Glaeske G. Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf. 2010;19:1071–7.PubMedCrossRefGoogle Scholar
Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol. 2007;21(7):774–82.PubMedCrossRefGoogle Scholar
Béland SG, Préville M, Dubois MF, Lorrain D, Voyer P, Bossé C, et al. Scientific committee of the ESA study: the association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatr. 2011;26:908–15.CrossRefGoogle Scholar
Polić-Vižintin M, Štimac D, Šostar Z, Tripković I. Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Serv Res. 2014;14:343.PubMedPubMedCentralCrossRefGoogle Scholar
Rouby F, Pradel V, Frauger E, Pauly V, Natali F, Reggio P, et al. Assessment of abuse of tianeptine from a reimbursement database using 'doctor-shopping' as an indicator. Fundam Clin Pharmacol. 2012;26:286–94.PubMedCrossRefGoogle Scholar
Croatian Bureau of Statistics. Census of Population, Households and Dwellings in the Republic of Croatia in 2011. https://www.dzs.hr. Accessed 11 Sep 2018.
Croatian Bureau of Statistics. 48th Statistical Yearbook of the Republic of Croatia. 2016. https://www.dzs.hr/. Accessed 11 Sep 2018.
Vojvodić Ž, Nelken-Bestvina D, Kurc- Bionda A, Štimac D. Trends in prescribing in primary care in Croatia, 2000–2012: prescribing volume, costs and regulatory measures. Coll Antropol. 2014;38(S2):67–72.PubMedGoogle Scholar
Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73:927–35.PubMedCrossRefGoogle Scholar
Urzal J, Pedro AB, Oliveira IF, Romero I, Achega M, Correia I, et al. Inappropriate prescribing to elderly patients in an internal medicine ward. Acta Med Port. 2019;32:141–8.PubMedCrossRefGoogle Scholar
Sánchez V, Pilar M, Macías Saint-Gerons D, Cdela FH, González Bermejo D, Montero Corominas D et al. Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el período 2000–2011. Revista Española de Salud Pública. 2013;87:247–55.CrossRefGoogle Scholar
Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, et al. Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users. Eur J Clin Pharmacol. 2016;72:869–76.PubMedCrossRefGoogle Scholar
Barbui C. Drug epidemiology in Italy: methods and ethical issues: The example of psychiatry. Pharmacoepidemiol Drug Saf. 2001;10:647–52.PubMedCrossRefGoogle Scholar
Kapil V, Green JL, Le Lait C, Wood DM, Dargan PI. Misuse of benzodiazepines and Z-drugs in the UK. Br J Psychiatr. 2014;205:407–8.CrossRefGoogle Scholar
Naqvi H, Sabzwari S, Hussain S, Islam M, Zaman M. General practitioners' awareness and management of common psychiatric disorders: a community-based survey from Karachi. Pak East Mediterr Health J. 2012;18:446–53.CrossRefGoogle Scholar
Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51:671–7.PubMedCrossRefGoogle Scholar
Voyer P, Préville M, Cohen D, Berbiche D, Béland SG. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging. 2010;29:205–13.PubMedCrossRefGoogle Scholar
Sonnenberg CM, Bierman EJ, Deeg DJ, Comijs HC, van Tilburg W, Beekman AT. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatr Psychiatr Epidemiol. 2012;47:293–301.CrossRefGoogle Scholar
Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, et al. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiol Drug Saf. 2018;27:674–82.PubMedCrossRefGoogle Scholar
Vlastelica M, Jelaska M. Zašto su benzodiazepini još uvijek u širokoj primjeni? Acta Med Croatica. 2012;66:137–40.PubMedGoogle Scholar
Millar A, Hughes C, Ryan C. Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: a cross-sectional observational study. Int J Clin Pharm. 2017;39:527–35.PubMedPubMedCentralCrossRefGoogle Scholar
Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs’ attitudes to benzodiazepine and “Z-drug” prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract. 2006;56:964–7.PubMedPubMedCentralGoogle Scholar
Popović B, Quadranti NR, Matanović SM, Lisica ID, Ljubotina A, Duliba DP, et al. Potentially inappropriate prescribing in elderly outpatients in Croatia. Eur J Clin Pharmacol. 2014;70:737–44.PubMedCrossRefGoogle Scholar
Tournier M, Pariente A, Bégaud B, Bénard-Laribière A. Use and misuse of benzodiazepines out of France. Presse Med. 2018;47:882–5.PubMedCrossRefGoogle Scholar
Čulig J, Leppee M, Štimac D, Kuvačić I, Pulanić-Klepac T, Herman R, et al. Presječno istraživanje uporabe lijekova u trudnoći. Lijec Vjesn. 2007;129:253–9.PubMedGoogle Scholar
Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13:214–23.PubMedPubMedCentralGoogle Scholar
Vlahović-Palcevski V, Bergman U. Quality of prescribing for the elderly in Croatia-computerized pharmacy data can be used to screen for potentially inappropriate prescribing. Eur J Clin Pharmacol. 2004;60:217–20.PubMedCrossRefGoogle Scholar
Divac N, Jasović M, Djukić L, Vujnović M, Babić D, Bajcetić M, et al. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf. 2004;13:315–22.PubMedCrossRefGoogle Scholar
Petrushevska T, Stefanovska VV. Use of Medicines from the Group of Benzodiazepines in the Period of 2003–2013 Year in the Republic of Macedonia. Open Access Maced J Med Sci. 2015;3:151–7.PubMedGoogle Scholar
Sidorchuk A, Isomura K, Molero Y, Hellner C, Lichtenstein P, Chang Z, et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study. PLoS Med. 2018;15:e1002635.PubMedPubMedCentralCrossRefGoogle Scholar
Ndukwe HC, Tordoff JM, Wang T, Nishtala PS. Psychotropic medicine utilization in older people in New Zealand from 2005 to 2013. Drugs Aging. 2014;31:755–68.PubMedCrossRefGoogle Scholar
Rapić M, Cikač T, Barišić-Marčac Z, Štimac D. Trends in psychotropic drug utilization in Croatia. Coll Antropol. 2014;38:S37–S42.Google Scholar
Štimac D, Vukušić I, Čulig J, Šostar Z. Comparison of outpatient utilization of psychopharmaceuticals between Croatia and Scandinavian countries (2001–2003). Medicinski Glasnik. 2007;4:14–20.Google Scholar
Balon R, Chouinard G, Cosci F, Dubovsky SL, Fava GA, Freire RC, et al. International task force on benzodiazepines. Psychother Psychosom. 2018;87:193–4.PubMedCrossRefGoogle Scholar
Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, et al. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 2013;27:967–71.PubMedCrossRefGoogle Scholar
Paulozzi LJ, Mack KA, Hockenberry JM. Variation among states in prescribing of opioid pain relievers and benzodiazepines–United States, 2012. J Safety Res. 2014;51:125–9.PubMedCrossRefGoogle Scholar
Potočnjak I, Likić R, Degoricija V, Nham E, Wettermark B. The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015. Expert Rev Pharmacoecon Outcomes Res. 2018;18:641–6.PubMedCrossRefGoogle Scholar
Johnson CF, Frei C, Downes N, McTaggart SA, Akram G. Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. Br J Gen Pract. 2016;66:e410–e415415.PubMedPubMedCentralCrossRefGoogle Scholar
Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, van de Lisdonk EH, Breteler MH, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatr. 2003;182:498–504.CrossRefGoogle Scholar